XORTX Therapeutics Inc
NASDAQ:XRTX

Watchlist Manager
XORTX Therapeutics Inc Logo
XORTX Therapeutics Inc
NASDAQ:XRTX
Watchlist
Price: 0.5775 USD -0.77% Market Closed
Market Cap: 1.7m USD

Operating Margin
XORTX Therapeutics Inc

0%
Current
0%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-3.2m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

XORTX Therapeutics Inc
Glance View

Market Cap
1.7m USD
Industry
Pharmaceuticals

XORTX Therapeutics, Inc. is a biopharmaceutical company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-09-30. The firm is focused on identifying, developing and commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD) and type 2 diabetic nephropathy (T2DN) as well as acute kidney injury (AKI) due to coronavirus infection. Its lead product candidates are XRx-008, XRx-101 and XRx-225. XRx-008 is a late clinical stage program focused on demonstrating the potential of its therapy for ADPKD. XRx-101 is a program to treat acute kidney injury associated with Coronavirus/ COVID-19 infection, AKI and associated health consequences. XRx-225 is a program for the treatment of T2DN. The company is also working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid.

XRTX Intrinsic Value
0.543 USD
Overvaluation 6%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-3.2m
/
Revenue
0
What is the Operating Margin of XORTX Therapeutics Inc?

Based on XORTX Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top